Grown Rogue International (GRUSF) EBITDA Margin (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly EBITDA Margin of 24.18% in Q1 2026, down 174.7% quarter-over-quarter from 32.36% in Q4 2025, and down 3467.0% on a YoY basis from 0.72% in Q1 2025.
Grown Rogue International (GRUSF) EBITDA Margin (2009 - 2026) Analysis & Trends
Grown Rogue International's EBITDA Margin history runs 16 years deep, the most recent figure standing at 24.18% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 3467.0% year-over-year to 24.18%; the TTM figure through Mar 2026 stood at 44.86% (down 2637391777.0% YoY), while the FY2025 annual figure was 9.97%, up 7006.0% from the prior year.
- EBITDA Margin was 24.18% for Q1 2026 at Grown Rogue International, down from 32.36% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 46634271.92% in Q4 2024 to a low of 13026428.44% in Q3 2024.
- Historically, EBITDA Margin has averaged 2240519.74% across 5 years, with a median of 6.18% in 2023.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin soared 2000000000 bps in 2024, then slumped 2000000000 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 3.8% in 2022, then jumped by 391 bps to 18.65% in 2023, then surged by 250038643 bps to 46634271.92% in 2024, then sank by 100 bps to 32.36% in 2025, then slumped by 175 bps to 24.18% in 2026.
- The last three EBITDA Margin figures came in at 24.18% (Q1 2026), 32.36% (Q4 2025), and 52.91% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -24.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.18% |
| Dec 31, 2025 | 32.36% |
| Sep 30, 2025 | 52.91% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 10.50% |
| Dec 31, 2024 | 46,634,271.92% |
| Sep 30, 2024 | -13,026,428.44% |
| Jun 30, 2024 | -98.20% |
| Mar 31, 2024 | -62.64% |
| Dec 31, 2023 | 18.65% |
| Oct 31, 2023 | -6.68% |
| Jul 31, 2023 | 6.18% |
| Apr 30, 2023 | 6.83% |
| Jan 31, 2023 | 13.05% |
| Jan 31, 2022 | 3.80% |
| Oct 31, 2021 | 29.50% |
| Jul 31, 2021 | 7.55% |
| Apr 30, 2021 | -93.59% |
| Jan 31, 2021 | -101.95% |
| Jul 31, 2020 | -120.63% |